Search details
1.
Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
Immunity
; 53(2): 442-455.e4, 2020 08 18.
Article
in English
| MEDLINE | ID: mdl-32668194
2.
Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication.
Mol Cell
; 80(1): 164-174.e4, 2020 10 01.
Article
in English
| MEDLINE | ID: mdl-32877642
3.
TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
Proc Natl Acad Sci U S A
; 121(23): e2407437121, 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38814864
4.
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
N Engl J Med
; 389(1): 22-32, 2023 Jul 06.
Article
in English
| MEDLINE | ID: mdl-37345876
5.
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
Nature
; 583(7816): 469-472, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32408336
6.
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
Nature
; 587(7835): 657-662, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32726803
7.
SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.
PLoS Biol
; 20(11): e3001871, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36383605
8.
SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells.
Mol Cell Proteomics
; 22(5): 100537, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37001587
9.
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial.
J Hepatol
; 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38734383
10.
Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models.
J Med Virol
; 96(1): e29354, 2024 01.
Article
in English
| MEDLINE | ID: mdl-38180134
11.
Pediatric cancer patients vaccinated against SARS-CoV-2-a clinical and laboratory follow-up.
Support Care Cancer
; 32(4): 221, 2024 Mar 11.
Article
in English
| MEDLINE | ID: mdl-38467829
12.
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Gut
; 72(6): 1186-1195, 2023 06.
Article
in English
| MEDLINE | ID: mdl-35977815
13.
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure.
Am J Physiol Cell Physiol
; 325(1): C129-C140, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-37273239
14.
Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer.
Clin Infect Dis
; 76(3): e510-e513, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-35901198
15.
SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination.
Eur J Immunol
; 52(7): 1194-1197, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35389515
16.
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model.
Eur J Immunol
; 52(5): 770-783, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34355795
17.
Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection.
J Med Virol
; 95(3): e28686, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36938992
18.
Repurposing of the antibiotic nitroxoline for the treatment of mpox.
J Med Virol
; 95(3): e28652, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36897017
19.
An appeal for strengthening genomic pathogen surveillance to improve pandemic preparedness and infection prevention: the German perspective.
Infection
; 51(4): 805-811, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37129842
20.
[Establishment of genomic pathogen surveillance to strengthen pandemic preparedness and infection prevention in Germany]. / Etablierung der Genomischen Erreger-Surveillance zur Stärkung des Pandemie- und Infektionsschutzes in Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 66(4): 443-449, 2023 Apr.
Article
in German
| MEDLINE | ID: mdl-36811648